Bausch Health Companies (BHC) Earnings Analysis

Bausch Health Companies (BHC) next reports earnings on 2026-07-29, consensus EPS 0.96 USD. Last quarter (2026-04-29) it missed with EPS 0.78 USD vs 0.81 USD est (-3.7%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -1.42.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BHC next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate0.96 USD
Revenue estimate2.59B

BHC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.78 USD0.81 USD-3.7%Miss
2026-02-181.08 USD1.21 USD-10.7%Miss
2025-07-300.9 USD0.97 USD-7.2%Miss
2025-04-300.59 USD0.83 USD-28.9%Miss
2025-02-191.15 USD1.65 USD-30.3%Miss
2024-10-301.12 USD1.03 USD+8.7%Beat
2024-08-010.89 USD0.88 USD+1.1%Beat

Beat rate: 2/7 (29%) over reported quarters with consensus data.

BHC valuation and analyst view

Trailing P/E-1.42
Trailing EPS-3.19069 USD
Price / book-0.83
Dividend yield0.00%
Market cap1.72B
Analyst consensusBuy (19 buy / 15 hold / 4 sell)
Avg price target8 USD

Related research pages

Frequently asked questions

When is Bausch Health Companies (BHC)'s next earnings date?

Bausch Health Companies is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.96 USD and revenue estimate of 2.59B.

Did BHC beat earnings last quarter?

In its 2026-04-29 report, BHC posted EPS of 0.78 USD versus a 0.81 USD estimate — a miss of 3.7%.

What is BHC's earnings track record?

Over the last 7 reported quarters with consensus data, BHC beat estimates 2 times (29%).

What is BHC's current P/E ratio and EPS?

BHC trades at a trailing P/E of -1.42 on trailing EPS of -3.1906876287553647 USD.

What do analysts rate BHC?

Analyst consensus is "Buy" across 38 ratings (0 strong buy, 19 buy, 15 hold, 4 sell, 0 strong sell). Average 12-month price target: 8 USD.